Some hormone prescriptions are restricted
Prescribers cannot prescribe these medicines for gender incongruence or dysphoria, with an exception for people already prescribed them.
Medicines (Restriction on Prescribing Gonadotropin-releasing Hormone Analogues) Amendment Regulations 2025 · Starts 19 Dec 2025
What's changing
Prescribing for gender incongruence or dysphoria
Authorised prescribers must not prescribe gonadotropin-releasing hormone analogue medicines for treating gender incongruence or gender dysphoria. The restriction does not apply to a person who was prescribed one of these medicines for that treatment before 19 December 2025.
Penalty for breaching the restriction
An authorised prescriber who breaches the prescribing restriction commits an offence and may be fined up to $500 if convicted.
Medicines covered
The restriction covers buserelin, deslorelin, gonadorelin, goserelin, leuprorelin, nafarelin, and triptorelin.
Who's affected
Authorised prescribers and people seeking these medicines for gender incongruence or gender dysphoria are affected.
When
These rules will apply from 19 December 2025.
Background
The regulations amend the Medicines Regulations 1984 to restrict this prescribing and create an offence for breaches.